Loading…

Decreased expression of E-cadherin in the progression of rat prostatic cancer

Cadherins represent a family of Ca(2+)-dependent cell adhesion molecules involved in homotypic, homophilic cell-cell interactions. Recent studies have shown that the cadherins can play a role in invasive and metastatic behavior. Using the established Dunning R-3327 model system of serially transplan...

Full description

Saved in:
Bibliographic Details
Published in:Cancer research (Chicago, Ill.) Ill.), 1992-05, Vol.52 (10), p.2916-2922
Main Authors: BUSSEMAKERS, M. J. G, VAN MOORSELAAR, R. J. A, GIROLDI, L. A, ICHIKAWA, T, ISAACS, J. T, TAKEICHI, M, DEBRUYNE, F. M. J, SCHALKEN, J. A
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 2922
container_issue 10
container_start_page 2916
container_title Cancer research (Chicago, Ill.)
container_volume 52
creator BUSSEMAKERS, M. J. G
VAN MOORSELAAR, R. J. A
GIROLDI, L. A
ICHIKAWA, T
ISAACS, J. T
TAKEICHI, M
DEBRUYNE, F. M. J
SCHALKEN, J. A
description Cadherins represent a family of Ca(2+)-dependent cell adhesion molecules involved in homotypic, homophilic cell-cell interactions. Recent studies have shown that the cadherins can play a role in invasive and metastatic behavior. Using the established Dunning R-3327 model system of serially transplantable rat prostate cancers, the expression of E- and P-cadherin in rat prostatic cancer was studied. Analysis within this system demonstrated that whereas E-cadherin was expressed in the normal rat prostate and the well- or moderately differentiated, noninvasive Dunning tumors, no expression, either at the mRNA or at the protein level, could be detected in the invasive sublines. Since not all invasive Dunning tumors studied have metastatic ability, these results suggest that a decreased expression of E-cadherin is correlated with invasive behavior rather than with metastatic ability. Recently, genetic instability occurred in an animal bearing the well differentiated, androgen-responsive, slow growing, nonmetastatic Dunning R-3327-H rat prostate cancer resulting in the progression to an anaplastic, androgen-independent, fast growing, highly metastatic state. This spontaneously arising tumor, termed the AT6 subline, in its original host was heterogeneously composed of both a well differentiated and an anaplastic population of cancer cells in which areas of squamous cell differentiation were occasionally observed. The original animal bearing this heterogeneous AT6 cancer developed multiple metastases, the lung metastases being heterogeneously composed of anaplastic and squamous cell populations. Cytogenetic analysis demonstrated that the lung metastases were derived from a specific subpopulation of cancer cells present in the original AT6 primary tumor. Immunohistochemical studies demonstrated that only the area of lung metastases displaying squamous morphology were positive for E-cadherin. In contrast, the anaplastic areas of the lung metastases and the metastases in other organs were E-cadherin negative. By the first passage of the AT6 tumor only the anaplastic cells were present and no detectable E-cadherin mRNA or protein was found in the primary tumor and metastatic deposits. These results suggest that a decreased expression of E-cadherin is associated with the progression of prostatic cancer.
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_72947735</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72947735</sourcerecordid><originalsourceid>FETCH-LOGICAL-h300t-a35565de99fa6ba4a5e1ccba0b551bc16ed4069eaf01024579cccddea32a5a7d3</originalsourceid><addsrcrecordid>eNqFkEFLxDAQhYMo67r6E4QexFshaTJNc5R1XYUVL3ou02RqK912TVrQf2_EIt6EgWHmfQxv3hFbCpBFqpWCY7bknBcpKJ2dsrMQ3uIIgsOCLQQUwnCzZI-3ZD1hIJfQx8FTCO3QJ0OdbFKLriHf9kmssaHk4IfXP4DH8XsVRhxbm1jsLflzdlJjF-hi7iv2crd5Xt-nu6ftw_pmlzaS8zFFCZCDI2NqzCtUCCSsrZBXAKKyIieneG4Iay54pkAba61zhDJDQO3kil3_3I0G3icKY7lvg6Wuw56GKZQ6M0prCf-CIldFbjIZwcsZnKo9ufLg2z36z3IOKupXs47BYlf7-G8bfjEVQy-4ll-QJ3LJ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16486923</pqid></control><display><type>article</type><title>Decreased expression of E-cadherin in the progression of rat prostatic cancer</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>BUSSEMAKERS, M. J. G ; VAN MOORSELAAR, R. J. A ; GIROLDI, L. A ; ICHIKAWA, T ; ISAACS, J. T ; TAKEICHI, M ; DEBRUYNE, F. M. J ; SCHALKEN, J. A</creator><creatorcontrib>BUSSEMAKERS, M. J. G ; VAN MOORSELAAR, R. J. A ; GIROLDI, L. A ; ICHIKAWA, T ; ISAACS, J. T ; TAKEICHI, M ; DEBRUYNE, F. M. J ; SCHALKEN, J. A</creatorcontrib><description>Cadherins represent a family of Ca(2+)-dependent cell adhesion molecules involved in homotypic, homophilic cell-cell interactions. Recent studies have shown that the cadherins can play a role in invasive and metastatic behavior. Using the established Dunning R-3327 model system of serially transplantable rat prostate cancers, the expression of E- and P-cadherin in rat prostatic cancer was studied. Analysis within this system demonstrated that whereas E-cadherin was expressed in the normal rat prostate and the well- or moderately differentiated, noninvasive Dunning tumors, no expression, either at the mRNA or at the protein level, could be detected in the invasive sublines. Since not all invasive Dunning tumors studied have metastatic ability, these results suggest that a decreased expression of E-cadherin is correlated with invasive behavior rather than with metastatic ability. Recently, genetic instability occurred in an animal bearing the well differentiated, androgen-responsive, slow growing, nonmetastatic Dunning R-3327-H rat prostate cancer resulting in the progression to an anaplastic, androgen-independent, fast growing, highly metastatic state. This spontaneously arising tumor, termed the AT6 subline, in its original host was heterogeneously composed of both a well differentiated and an anaplastic population of cancer cells in which areas of squamous cell differentiation were occasionally observed. The original animal bearing this heterogeneous AT6 cancer developed multiple metastases, the lung metastases being heterogeneously composed of anaplastic and squamous cell populations. Cytogenetic analysis demonstrated that the lung metastases were derived from a specific subpopulation of cancer cells present in the original AT6 primary tumor. Immunohistochemical studies demonstrated that only the area of lung metastases displaying squamous morphology were positive for E-cadherin. In contrast, the anaplastic areas of the lung metastases and the metastases in other organs were E-cadherin negative. By the first passage of the AT6 tumor only the anaplastic cells were present and no detectable E-cadherin mRNA or protein was found in the primary tumor and metastatic deposits. These results suggest that a decreased expression of E-cadherin is associated with the progression of prostatic cancer.</description><identifier>ISSN: 0008-5472</identifier><identifier>EISSN: 1538-7445</identifier><identifier>PMID: 1581909</identifier><identifier>CODEN: CNREA8</identifier><language>eng</language><publisher>Philadelphia, PA: American Association for Cancer Research</publisher><subject>Animal tumors. Experimental tumors ; Animals ; Biological and medical sciences ; Cadherins - analysis ; Cadherins - genetics ; Cadherins - physiology ; carcinoma ; correlation ; E-cadherin ; Experimental renal and urinary tract tumors ; expression ; Gene Expression Regulation, Neoplastic - genetics ; Gene Expression Regulation, Neoplastic - physiology ; Immunohistochemistry ; Karyotyping ; Male ; Medical sciences ; membrane proteins ; Neoplasm Invasiveness - genetics ; Neoplasm Metastasis - genetics ; Neoplasm Transplantation ; prostate ; Prostatic Neoplasms - genetics ; Prostatic Neoplasms - pathology ; Prostatic Neoplasms - physiopathology ; Rats ; Tumor Cells, Cultured ; Tumors</subject><ispartof>Cancer research (Chicago, Ill.), 1992-05, Vol.52 (10), p.2916-2922</ispartof><rights>1993 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=4538807$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1581909$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>BUSSEMAKERS, M. J. G</creatorcontrib><creatorcontrib>VAN MOORSELAAR, R. J. A</creatorcontrib><creatorcontrib>GIROLDI, L. A</creatorcontrib><creatorcontrib>ICHIKAWA, T</creatorcontrib><creatorcontrib>ISAACS, J. T</creatorcontrib><creatorcontrib>TAKEICHI, M</creatorcontrib><creatorcontrib>DEBRUYNE, F. M. J</creatorcontrib><creatorcontrib>SCHALKEN, J. A</creatorcontrib><title>Decreased expression of E-cadherin in the progression of rat prostatic cancer</title><title>Cancer research (Chicago, Ill.)</title><addtitle>Cancer Res</addtitle><description>Cadherins represent a family of Ca(2+)-dependent cell adhesion molecules involved in homotypic, homophilic cell-cell interactions. Recent studies have shown that the cadherins can play a role in invasive and metastatic behavior. Using the established Dunning R-3327 model system of serially transplantable rat prostate cancers, the expression of E- and P-cadherin in rat prostatic cancer was studied. Analysis within this system demonstrated that whereas E-cadherin was expressed in the normal rat prostate and the well- or moderately differentiated, noninvasive Dunning tumors, no expression, either at the mRNA or at the protein level, could be detected in the invasive sublines. Since not all invasive Dunning tumors studied have metastatic ability, these results suggest that a decreased expression of E-cadherin is correlated with invasive behavior rather than with metastatic ability. Recently, genetic instability occurred in an animal bearing the well differentiated, androgen-responsive, slow growing, nonmetastatic Dunning R-3327-H rat prostate cancer resulting in the progression to an anaplastic, androgen-independent, fast growing, highly metastatic state. This spontaneously arising tumor, termed the AT6 subline, in its original host was heterogeneously composed of both a well differentiated and an anaplastic population of cancer cells in which areas of squamous cell differentiation were occasionally observed. The original animal bearing this heterogeneous AT6 cancer developed multiple metastases, the lung metastases being heterogeneously composed of anaplastic and squamous cell populations. Cytogenetic analysis demonstrated that the lung metastases were derived from a specific subpopulation of cancer cells present in the original AT6 primary tumor. Immunohistochemical studies demonstrated that only the area of lung metastases displaying squamous morphology were positive for E-cadherin. In contrast, the anaplastic areas of the lung metastases and the metastases in other organs were E-cadherin negative. By the first passage of the AT6 tumor only the anaplastic cells were present and no detectable E-cadherin mRNA or protein was found in the primary tumor and metastatic deposits. These results suggest that a decreased expression of E-cadherin is associated with the progression of prostatic cancer.</description><subject>Animal tumors. Experimental tumors</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Cadherins - analysis</subject><subject>Cadherins - genetics</subject><subject>Cadherins - physiology</subject><subject>carcinoma</subject><subject>correlation</subject><subject>E-cadherin</subject><subject>Experimental renal and urinary tract tumors</subject><subject>expression</subject><subject>Gene Expression Regulation, Neoplastic - genetics</subject><subject>Gene Expression Regulation, Neoplastic - physiology</subject><subject>Immunohistochemistry</subject><subject>Karyotyping</subject><subject>Male</subject><subject>Medical sciences</subject><subject>membrane proteins</subject><subject>Neoplasm Invasiveness - genetics</subject><subject>Neoplasm Metastasis - genetics</subject><subject>Neoplasm Transplantation</subject><subject>prostate</subject><subject>Prostatic Neoplasms - genetics</subject><subject>Prostatic Neoplasms - pathology</subject><subject>Prostatic Neoplasms - physiopathology</subject><subject>Rats</subject><subject>Tumor Cells, Cultured</subject><subject>Tumors</subject><issn>0008-5472</issn><issn>1538-7445</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1992</creationdate><recordtype>article</recordtype><recordid>eNqFkEFLxDAQhYMo67r6E4QexFshaTJNc5R1XYUVL3ou02RqK912TVrQf2_EIt6EgWHmfQxv3hFbCpBFqpWCY7bknBcpKJ2dsrMQ3uIIgsOCLQQUwnCzZI-3ZD1hIJfQx8FTCO3QJ0OdbFKLriHf9kmssaHk4IfXP4DH8XsVRhxbm1jsLflzdlJjF-hi7iv2crd5Xt-nu6ftw_pmlzaS8zFFCZCDI2NqzCtUCCSsrZBXAKKyIieneG4Iay54pkAba61zhDJDQO3kil3_3I0G3icKY7lvg6Wuw56GKZQ6M0prCf-CIldFbjIZwcsZnKo9ufLg2z36z3IOKupXs47BYlf7-G8bfjEVQy-4ll-QJ3LJ</recordid><startdate>19920515</startdate><enddate>19920515</enddate><creator>BUSSEMAKERS, M. J. G</creator><creator>VAN MOORSELAAR, R. J. A</creator><creator>GIROLDI, L. A</creator><creator>ICHIKAWA, T</creator><creator>ISAACS, J. T</creator><creator>TAKEICHI, M</creator><creator>DEBRUYNE, F. M. J</creator><creator>SCHALKEN, J. A</creator><general>American Association for Cancer Research</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>8FD</scope><scope>FR3</scope><scope>M7Z</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>19920515</creationdate><title>Decreased expression of E-cadherin in the progression of rat prostatic cancer</title><author>BUSSEMAKERS, M. J. G ; VAN MOORSELAAR, R. J. A ; GIROLDI, L. A ; ICHIKAWA, T ; ISAACS, J. T ; TAKEICHI, M ; DEBRUYNE, F. M. J ; SCHALKEN, J. A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-h300t-a35565de99fa6ba4a5e1ccba0b551bc16ed4069eaf01024579cccddea32a5a7d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1992</creationdate><topic>Animal tumors. Experimental tumors</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Cadherins - analysis</topic><topic>Cadherins - genetics</topic><topic>Cadherins - physiology</topic><topic>carcinoma</topic><topic>correlation</topic><topic>E-cadherin</topic><topic>Experimental renal and urinary tract tumors</topic><topic>expression</topic><topic>Gene Expression Regulation, Neoplastic - genetics</topic><topic>Gene Expression Regulation, Neoplastic - physiology</topic><topic>Immunohistochemistry</topic><topic>Karyotyping</topic><topic>Male</topic><topic>Medical sciences</topic><topic>membrane proteins</topic><topic>Neoplasm Invasiveness - genetics</topic><topic>Neoplasm Metastasis - genetics</topic><topic>Neoplasm Transplantation</topic><topic>prostate</topic><topic>Prostatic Neoplasms - genetics</topic><topic>Prostatic Neoplasms - pathology</topic><topic>Prostatic Neoplasms - physiopathology</topic><topic>Rats</topic><topic>Tumor Cells, Cultured</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>BUSSEMAKERS, M. J. G</creatorcontrib><creatorcontrib>VAN MOORSELAAR, R. J. A</creatorcontrib><creatorcontrib>GIROLDI, L. A</creatorcontrib><creatorcontrib>ICHIKAWA, T</creatorcontrib><creatorcontrib>ISAACS, J. T</creatorcontrib><creatorcontrib>TAKEICHI, M</creatorcontrib><creatorcontrib>DEBRUYNE, F. M. J</creatorcontrib><creatorcontrib>SCHALKEN, J. A</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biochemistry Abstracts 1</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer research (Chicago, Ill.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>BUSSEMAKERS, M. J. G</au><au>VAN MOORSELAAR, R. J. A</au><au>GIROLDI, L. A</au><au>ICHIKAWA, T</au><au>ISAACS, J. T</au><au>TAKEICHI, M</au><au>DEBRUYNE, F. M. J</au><au>SCHALKEN, J. A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Decreased expression of E-cadherin in the progression of rat prostatic cancer</atitle><jtitle>Cancer research (Chicago, Ill.)</jtitle><addtitle>Cancer Res</addtitle><date>1992-05-15</date><risdate>1992</risdate><volume>52</volume><issue>10</issue><spage>2916</spage><epage>2922</epage><pages>2916-2922</pages><issn>0008-5472</issn><eissn>1538-7445</eissn><coden>CNREA8</coden><abstract>Cadherins represent a family of Ca(2+)-dependent cell adhesion molecules involved in homotypic, homophilic cell-cell interactions. Recent studies have shown that the cadherins can play a role in invasive and metastatic behavior. Using the established Dunning R-3327 model system of serially transplantable rat prostate cancers, the expression of E- and P-cadherin in rat prostatic cancer was studied. Analysis within this system demonstrated that whereas E-cadherin was expressed in the normal rat prostate and the well- or moderately differentiated, noninvasive Dunning tumors, no expression, either at the mRNA or at the protein level, could be detected in the invasive sublines. Since not all invasive Dunning tumors studied have metastatic ability, these results suggest that a decreased expression of E-cadherin is correlated with invasive behavior rather than with metastatic ability. Recently, genetic instability occurred in an animal bearing the well differentiated, androgen-responsive, slow growing, nonmetastatic Dunning R-3327-H rat prostate cancer resulting in the progression to an anaplastic, androgen-independent, fast growing, highly metastatic state. This spontaneously arising tumor, termed the AT6 subline, in its original host was heterogeneously composed of both a well differentiated and an anaplastic population of cancer cells in which areas of squamous cell differentiation were occasionally observed. The original animal bearing this heterogeneous AT6 cancer developed multiple metastases, the lung metastases being heterogeneously composed of anaplastic and squamous cell populations. Cytogenetic analysis demonstrated that the lung metastases were derived from a specific subpopulation of cancer cells present in the original AT6 primary tumor. Immunohistochemical studies demonstrated that only the area of lung metastases displaying squamous morphology were positive for E-cadherin. In contrast, the anaplastic areas of the lung metastases and the metastases in other organs were E-cadherin negative. By the first passage of the AT6 tumor only the anaplastic cells were present and no detectable E-cadherin mRNA or protein was found in the primary tumor and metastatic deposits. These results suggest that a decreased expression of E-cadherin is associated with the progression of prostatic cancer.</abstract><cop>Philadelphia, PA</cop><pub>American Association for Cancer Research</pub><pmid>1581909</pmid><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0008-5472
ispartof Cancer research (Chicago, Ill.), 1992-05, Vol.52 (10), p.2916-2922
issn 0008-5472
1538-7445
language eng
recordid cdi_proquest_miscellaneous_72947735
source EZB-FREE-00999 freely available EZB journals
subjects Animal tumors. Experimental tumors
Animals
Biological and medical sciences
Cadherins - analysis
Cadherins - genetics
Cadherins - physiology
carcinoma
correlation
E-cadherin
Experimental renal and urinary tract tumors
expression
Gene Expression Regulation, Neoplastic - genetics
Gene Expression Regulation, Neoplastic - physiology
Immunohistochemistry
Karyotyping
Male
Medical sciences
membrane proteins
Neoplasm Invasiveness - genetics
Neoplasm Metastasis - genetics
Neoplasm Transplantation
prostate
Prostatic Neoplasms - genetics
Prostatic Neoplasms - pathology
Prostatic Neoplasms - physiopathology
Rats
Tumor Cells, Cultured
Tumors
title Decreased expression of E-cadherin in the progression of rat prostatic cancer
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T08%3A16%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Decreased%20expression%20of%20E-cadherin%20in%20the%20progression%20of%20rat%20prostatic%20cancer&rft.jtitle=Cancer%20research%20(Chicago,%20Ill.)&rft.au=BUSSEMAKERS,%20M.%20J.%20G&rft.date=1992-05-15&rft.volume=52&rft.issue=10&rft.spage=2916&rft.epage=2922&rft.pages=2916-2922&rft.issn=0008-5472&rft.eissn=1538-7445&rft.coden=CNREA8&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E72947735%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-h300t-a35565de99fa6ba4a5e1ccba0b551bc16ed4069eaf01024579cccddea32a5a7d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=16486923&rft_id=info:pmid/1581909&rfr_iscdi=true